TKNO
Alpha TeknovaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TKNO Profile
Alpha Teknova, Inc.
A leading provider of critical reagents for bioprocessing, bioproduction diagnostics for research, clinical, and applied markets
2451 Bert Dr., Hollister, CA 95023
--
Alpha Teknova, Inc., was originally incorporated in California on May 30, 2000 as "eTeknova Inc. ". On January 11, 2019, the Company filed a certificate of merger and merged with Alpha Teknova, Inc., a Delaware corporation, which continues as a surviving entity under the corporate name "Alpha Teknova, Inc.". The company is a leading supplier of key reagents, capable of discovering, developing and producing biopharmaceutical products such as drug therapies, new vaccines, molecular diagnostics, etc. The company's 3,000 active customers span the continuum of the life sciences market, including leading pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company is built around a highly adaptable and versatile proprietary development and manufacturing process. These proprietary processes enable the manufacture and delivery of high-quality, customized, made-to-order products with short turnaround time and scale at all stages of customer product development (including commercialization).
